A61K 40/4228
Platelet-derived growth factor [pdgf]
Official title: {Platelet-derived growth factor [PDGF]}
A61K40/4228 (Platelet-derived growth factor [pdgf]) appears on 2 US grants and 4 published applications in this corpus.
Search patents in A61K- Granted patents
- 2
- Published applications
- 4
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 7 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Single-chain fragment variable targeting human pdgfr-beta and use thereof in car-t cell immunotherapy5 Mar 2026US 2026/0061005 A1Shandong University
- Activation of natural cyotoxicity receptor 2 (ncr2)13 Feb 2020US 2020/0046770 A1Washington University
- Gene therapy for the prevention of autoimmune disease15 May 2003US 2003/0091548 A1The Board of Trustees of the Leland Stanford Junior University
- Genetic manipulation of phagocytes for modulation of antigen processing and the immune response therefrom17 Apr 2003US 2003/0072743 A1
Most cited
By later US patents